New treatments for multiple sclerosis.Focuses on treatment approaches to multiple sclerosis in Great Britain. Possible delay in the progress of irrecoverable neurological deficit; Results of three randomized controlled trials in ambulant patients with little or moderate disability.McDonald...
Some of the newer treatments target, while blunting the actions of, particular classes of immune cells now known to be involved in an MS attack. Others work even more subtly. For example, in MS, part of the immune reaction promotes changes in the blood-brain barrier, a tightly knit network...
Chapter 36 – New treatments for multiple sclerosisChapter 36 – New treatments for multiple sclerosisThis chapter presents an overview of new treatments for multiple sclerosis (MS). MS is a disease of the central nervous system (CNS) in which the demyelination and synthesis of immunoglobu...
Multiple Sclerosis (MS) is a chronic, inflammatory, autoimmune disease of the central nervous system that disrupts communication between the brain and other parts of the body.
REVIEWS Natalizumab: A new treatment for relapsing remitting multiple sclerosis Michael Hutchinson Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland Abstract: Natalizumab, a new disease-modifying therapy for relapsing remitting multiple sclerosis (RRMS), is a humanized monoclonal ...
(Medical Xpress)—New treatments for multiple sclerosis (MS) using common anti-psychotic agents have been discovered by Victoria University of Wellington researchers.
Register for alerts If you have registered for alerts, you should use your registered email address as your username Citation tools Download this article to citation manager McDonald W I. New treatments for multiple sclerosis BMJ 1995; 310:345 BibTeX (win & mac)Download EndNote (tagged)Dow...
Multiple sclerosis, an autoimmune disease of the central nervous system that affects millions worldwide, can cause debilitating symptoms for those who suffer from it. Though treatments exist, researchers are still searching for therapies that could more effectively treat the disease, or even prevent it...
Since both interferon-尾 (IFN-尾) and the antiretroviral drugs AZT and Indinavir, the standard treatments for MS patients or HIV-infected patients, respectively, are able to inhibit MMP-9 expression in glial cell cultures, their use could be very effective in MS treatment.(3) With regard to...
被引量: 0发表: 2014年 Clinical neurophysiology of multiple sclerosis. The availability of new treatments able to modify the natural course of multiple sclerosis (MS) has generated interest in paraclinical measures to monitor ... L Leocani,G Comi - Elsevier 被引量: 13发表: 2014年 加载更多研...